Benner A - Search Results

1

Preponderance of the oncogenic V599E and V599K mutations in B-raf kinase domain is enhanced in melanoma cutaneous/subcutaneous metastases.

Deichmann M, Thome M, Benner A, Kirschner M, Hassanzadeh J, Kurzen H. Deichmann M, et al. Among authors: benner a. BMC Cancer. 2005 Jun 3;5:58. doi: 10.1186/1471-2407-5-58. BMC Cancer. 2005. PMID: 15935100 Free PMC article.

2

S100-Beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma.

Deichmann M, Benner A, Bock M, Jäckel A, Uhl K, Waldmann V, Näher H. Deichmann M, et al. Among authors: benner a. J Clin Oncol. 1999 Jun;17(6):1891-6. doi: 10.1200/JCO.1999.17.6.1891. J Clin Oncol. 1999. PMID: 10561230

3

Interleukin-6 and its surrogate C-reactive protein are useful serum markers for monitoring metastasized malignant melanoma.

Deichmann M, Benner A, Waldmann V, Bock M, Jäckel A, Näher H. Deichmann M, et al. Among authors: benner a. J Exp Clin Cancer Res. 2000 Sep;19(3):301-7. J Exp Clin Cancer Res. 2000. PMID: 11144523

4

Are responses to therapy of metastasized malignant melanoma reflected by decreasing serum values of S100beta or melanoma inhibitory activity (MIA)?

Deichmann M, Benner A, Kuner N, Wacker J, Waldmann V, Näher H. Deichmann M, et al. Among authors: benner a. Melanoma Res. 2001 Jun;11(3):291-6. doi: 10.1097/00008390-200106000-00011. Melanoma Res. 2001. PMID: 11468518

5

PTEN/MMAC1 expression in melanoma resection specimens.

Deichmann M, Thome M, Benner A, Egner U, Hartschuh W, Näher H. Deichmann M, et al. Among authors: benner a. Br J Cancer. 2002 Dec 2;87(12):1431-6. doi: 10.1038/sj.bjc.6600653. Br J Cancer. 2002. PMID: 12454773 Free PMC article.

6

Somatic mitochondrial mutations in melanoma resection specimens.

Deichmann M, Kahle B, Benner A, Thome M, Helmke B, Näher H. Deichmann M, et al. Among authors: benner a. Int J Oncol. 2004 Jan;24(1):137-41. Int J Oncol. 2004. PMID: 14654950

7

Melanoma metastasis is associated with enhanced expression of the syntenin gene.

Helmke BM, Polychronidis M, Benner A, Thome M, Arribas J, Deichmann M. Helmke BM, et al. Among authors: benner a. Oncol Rep. 2004 Aug;12(2):221-8. Oncol Rep. 2004. PMID: 15254681

8

Expression of the heat shock cognate protein HSP73 correlates with tumour thickness of primary melanomas and is enhanced in melanoma metastases.

Deichmann M, Polychronidis M, Benner A, Kleist C, Thome M, Kahle B, Helmke BM. Deichmann M, et al. Among authors: benner a. Int J Oncol. 2004 Aug;25(2):259-68. Int J Oncol. 2004. PMID: 15254721

9

B-raf exon 15 mutations are common in primary melanoma resection specimens but not associated with clinical outcome.

Deichmann M, Thome M, Benner A, Näher H. Deichmann M, et al. Among authors: benner a. Oncology. 2004;66(5):411-9. doi: 10.1159/000079490. Oncology. 2004. PMID: 15331929

10

BRAF mutations distinguish anorectal from cutaneous melanoma at the molecular level.

Helmke BM, Mollenhauer J, Herold-Mende C, Benner A, Thome M, Gassler N, Wahl W, Lyer S, Poustka A, Otto HF, Deichmann M. Helmke BM, et al. Among authors: benner a. Gastroenterology. 2004 Dec;127(6):1815-20. doi: 10.1053/j.gastro.2004.08.051. Gastroenterology. 2004. PMID: 15578519

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

560 results

Search Page

Filters